#USA #Deerfield #Baxter #Hemopatch #collagen pad

Baxter Introduces HEMOPATCH: A New Era in Hemostasis and Sealing

Baxter, a renowned name in medical technology, has recently unveiled its innovative hemostatic sealant, HEMOPATCH. This product consists of a collagen-based pad designed to effectively manage hemostasis and sealing in surgical settings. Notably, the new HEMOPATCH variant can be stored at room temperature, marking a significant advancement in medical technology and surgical convenience.

A Decade of Innovation

This launch follows a decade of successful market presence for Baxter, reflecting its commitment to continuous innovation in tissue management. As Steve Wallace, president of Baxter’s Advanced Surgery division, stated, the introduction of the room-temperature HEMOPATCH underscores the company’s dedication to improving surgical outcomes and patient safety.

After years of rigorous development, the HEMOPATCH has proven to enhance the efficiency of hemostatic procedures. It combines advanced materials with a robust structure to reinforce mechanical support during incision closures, ensuring that patient care is prioritized at every surgical step.

Mechanism of Action

The HEMOPATCH operates by leveraging the interaction of two key components which work effectively to create a fast and lasting hemostatic seal. The pad’s design features a special side coated with NHS-PEG, which plays a crucial role when it comes into contact with blood or other bodily fluids. Upon exposure, this component forms a hydrogel that notably improves adhesive properties and promotes effective sealing of the tissue surface.

In addition to this, the collagen component of the HEMOPATCH induces platelet aggregation when it encounters blood, leading to immediate clotting and subsequent fibrin formation, important for exhibiting hemostatic properties.

Preclinical studies indicate that the absorption and replacement by host tissue generally occur within approximately six to eight weeks. This reabsorption is largely influenced by various factors, including the amount of remaining product and the site of application. Importantly, clinical benefits include rapid sealing of tissues, prevention of leaks, and achieving effective hemostasis in a mere two minutes.

Long Shelf Life and Accessibility

Baxter’s HEMOPATCH not only offers the convenience of room-temperature storage but also boasts an impressive shelf life of three years. This feature is particularly beneficial for healthcare facilities, allowing for improved stock management and less waste in surgical environments.

In conclusion, HEMOPATCH is poised to transform hemostatic practices in surgical procedures, offering timely and efficient solutions. As Baxter positions itself at the forefront of surgical innovation, medical professionals and patients alike can expect enhanced safety and efficacy during critical surgical interventions.

For more information on the HEMOPATCH, its indications, and important risk information, healthcare professionals are encouraged to visit Baxter’s dedicated webpage at Advances Surgery - HEMOPATCH.